20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13074 | TAM-IN-2 | TAM Receptor | |
TAM-IN-2 is an inhibitor of TAM. | |||
T7425 | RU-301 | TAM Receptor | |
RU-301 is a novel pan-tam inhibitor | |||
T1968 | UNC2250 | TAM Receptor | |
UNC2250 is an effective and specific Mer inhibitor (IC50=1.7 nM). | |||
T6982 | SGI-7079 | FLT , c-Met/HGFR , c-RET , TAM Receptor , Src | |
SGI-7079 is a new selective Axl inhibitor. SGI-7079 can be a dose-dependent manner inhibited growth of tumors. It is also a potential therapeutic target for EGFR inhibitor resistance. | |||
TQ0041 | Ningetinib Tosylate | VEGFR , c-Met/HGFR , TAM Receptor | |
Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively. | |||
T2311 | LDC1267 | TAM Receptor | |
LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM). | |||
T17205 | UNC2541 | Others , FLT , TAM Receptor | |
UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor. It also binds in the MerTK ATP pocket (IC50: 4.4 nM). UNC2541 inhibits phosphorylated MerTK (pMerTK; EC50, 510 nM). | |||
T2005 | Dubermatinib | TP0903 | Apoptosis , TAM Receptor |
Dubermatinib (TP0903) is a potent and selective Axl kinase inhibitor. | |||
T9123 | DS-1205 | TAM Receptor | |
DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro an... | |||
T8327 | ONO-7475 | Trk receptor , TAM Receptor | |
ONO-7475 is an inhibitor with high specificity for anexelekto and MER tyrosine kinase | |||
T6907 | NPS-1034 | NPS1034,NPS 1034 | Apoptosis , c-Met/HGFR , TAM Receptor |
NPS-1034 is a dual Met/Axl inhibitor with IC50 of 48 nM and 10.3 nM, respectively. | |||
T2629 | UNC2881 | TAM Receptor | |
UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively. | |||
TQ0021 | Ningetinib | CT-053,CT053PTSA | VEGFR , c-Met/HGFR , TAM Receptor |
Ningetinib (CT-053) (CT053PTSA) is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively. | |||
T21302 | UNC569 | UNC 569 | TAM Receptor |
UNC569 (UNC 569) is a selective inhibitor of URAT1, a transporter in the kidney that regulates uric acid excretion from the body. It is also a selective uric acid re-absorption inhibitor. UNC569 could normalize the amoun... | |||
T4426 | CEP-40783 | CEP 40783,RXDX-106 | c-Met/HGFR , TAM Receptor |
CEP-40783 (RXDX-106) is an effective, specific and orally active AXL/c-Met inhibitor (IC50: 7/12 nM). It also inhibits MER and TYRO3 (IC50: 29/19 nM). | |||
T6269 | Bemcentinib | R428,BGB324 | TAM Receptor |
Bemcentinib (R428) is a selective inhibitor of Axl (IC50: 14 nM) and has been investigated for the treatment of NSCLC. | |||
T2699 | BMS 777607 | BMS777607,BMS-777607,BMS 817378 | c-Met/HGFR , TAM Receptor |
BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3 (IC50: 3.9/1.1/1.8/4.3 nM). BMS-777607 has been investigated for the basic science of Malignant Solid Tumour. | |||
T4409 | Gilteritinib | ASP2215 | FLT , TAM Receptor , c-Kit |
Gilteritinib (ASP2215) is a potent inhibitor at the FMS-related tyrosine kinase 3 (FLT3) and AXL tyrosine kinase receptors (IC50 = 0.29 nM and <1 nM, respectively). In preClinicalal studies, gilteritinib showed strong an... | |||
T9052 | XL092 | CL-092,JUN04542 | VEGFR , c-Met/HGFR , TAM Receptor |
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders. | |||
T7379 | 2-D08 | E1/E2/E3 Enzyme , TAM Receptor | |
2-D08 is a synthetic flavone that inhibits sumoylation, also inhibits Axl with an IC50 of 0.49 nM.2-D08 showed anti-aggregatory and neuroprotective effect. |